Aardvark Therapeutics (AARD) Profit After Tax (2024 - 2026)
Aardvark Therapeutics (AARD) reported Profit After Tax of -$21.6 million for Q1 2026, down 131.88% on a YoY basis from $67.7 million in Q1 2025, and down 22.67% sequentially from -$17.6 million in Q4 2025.
Aardvark Therapeutics (AARD) Profit After Tax (2024 - 2026) Analysis & Trends
Aardvark Therapeutics (AARD) has 3 years of Profit After Tax data on file, last reported at -$21.6 million in Q1 2026.
- For the quarter ending Q1 2026, Profit After Tax fell 131.88% year-over-year to -$21.6 million; the trailing twelve-month figure through Mar 2026 stood at -$69.9 million (down 152.05% YoY), and the FY2025 full-year result was -$57.6 million, down 179.73% from the prior year.
- Profit After Tax fell to -$21.6 million in Q1 2026, from -$17.6 million in the prior quarter.
- In the past five years, Profit After Tax ranged from a high of -$2.2 million in Q1 2024 to a low of -$21.6 million in Q1 2026.
- A 3-year average of -$11.1 million and a median of -$9.3 million in 2025 frame the typical range for Profit After Tax.
- Peak annual rise in Profit After Tax reached 100.46% in 2025, while the deepest fall reached 327.46% in 2025.
- Tracing AARD's Profit After Tax over 3 years: stood at -$8.8 million in 2024, then sank by 100.46% to -$17.6 million in 2025, then slipped by 22.67% to -$21.6 million in 2026.
- Business Quant data shows AARD's Profit After Tax at -$21.6 million in Q1 2026, -$17.6 million in Q4 2025, and -$16.3 million in Q3 2025.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | PAT (Qtr) |
|---|---|---|---|---|---|
| 1 | Oculis Holding AG | 68,785.72 Bn | 68,785.72 Bn | - | -36.84 Mn |
| 2 | Nanobiotix | 1,895.57 Bn | 1,895.51 Bn | - | - |
| 3 | BeOne Medicines | 471.35 Bn | 466.56 Bn | 1.35 Bn | 227.36 Mn |
| 4 | NuCana | 279.75 Bn | 279.75 Bn | - | - |
| 5 | Vertex Pharmaceuticals | 120.24 Bn | 113.00 Bn | 2.59 Bn | 1.03 Bn |
| 6 | Regeneron Pharmaceuticals | 67.80 Bn | 59.04 Bn | 3.31 Bn | -65.60 Mn |
| 7 | Belite Bio | 62.51 Bn | 62.51 Bn | - | -26.94 Mn |
| 8 | Argenx Se | 57.38 Bn | 57.38 Bn | 1.41 Bn | 362.00 Mn |
| 9 | Revolution Medicines | 37.78 Bn | 37.78 Bn | - | -453.82 Mn |
| 10 | Aardvark Therapeutics | 139.40 Mn | 19.44 Mn | - | -21.59 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | -21.59 Mn |
| Dec 31, 2025 | -17.60 Mn |
| Sep 30, 2025 | -16.32 Mn |
| Jun 30, 2025 | -14.37 Mn |
| Mar 31, 2025 | -9.31 Mn |
| Dec 31, 2024 | -8.78 Mn |
| Sep 30, 2024 | -4.18 Mn |
| Jun 30, 2024 | -5.45 Mn |
| Mar 31, 2024 | -2.18 Mn |